Press release 17 April 2007 BioGaia signs agreement with Sunstar BioGaia has signed another agreement with Sunstar Suisse SA, which gives Sunstar an exclusive option to distribute BioGaia's oral health products in a large number of countries globally. Sunstar is one of the ten largest oral health companies in the world and its flagship brand GUM is the number one brand in Japan and is presently sold in more than 75 countries in the world. From an earlier agreement Sunstar has the right to sell BioGaia's oral health products in Germany, France, Italy and Spain. The launch in these countries will start in April 2007 under the GUM PerioBalance brand. The first launch under the option agreement is expected to take place in the USA during 2008. The products, that are effective against gingivitis and plaque, will be sold through pharmacies and dental clinics. ”So far the key application of probiotics has been the gastrointestinal tract. This innovation strongly leverages the link between oral diseases and systemic diseases. Our global brand GUM crystallizes in its own tagline, this perfect fit:”Healthy Gums, Healthy Life””, says Mr. Gino Borrelli, President, E.ME.A, Sunstar Suisse. “The expanded cooperation with one of the largest oral health companies in the world for the important American market, shows that our investment within the oral health now is starting to bear fruit” says Peter Rothschild, President BioGaia AB. “The agreement is of major importance to BioGaia and might very well make Sunstar one of our largest clients within a few years” adds Peter Rothschild. Latest press releases from BioGaia: 2007-03-29 BioGaia signs agreement in USA 2007-03-22 Notice of Annual General Meeting 2007-03-05 BioGaia signs new agreement with Semper For additional information contact: Peter Rothschild, president, telephone: +46 (0)8 - 555 293 00 Jan Annwall, executive vice president, telephone: +46 (0)8 - 555 293 00 -------------------------------------------------------------------------------- ----------------------------------------------------------- BioGaia is a biotechnology company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri (Reuteri), which has health-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Small Cap list of the Nordic Exchange in Stockholm. www.biogaia.com